Key insights from Accounting Today’s Top 100 Firms and Regional Leaders report, from the many ramifications of private equity to the impact of demographics and much, much more.
A recent report has found that the majority of cryptocurrency holders are aware transactions are taxable and want to comply, but struggle with actually doing so.
Serial biotech investor Kevin Tang previously unsuccessfully tried to buy Kezar Life Sciences via Concentra Biosciences, a biotech consolidation company owned by the venture capital firm he runs.
Takeda’s layoffs include cutting 247 people in Massachusetts. The workforce reduction is meant to help offset investments in areas including a product launch for oral drug candidate zasocitinib, for which the pharma today announced positive Phase 3 data.
Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this year.
A recent study by the Treasury Inspector General for Tax Administration found that the IRS has spent $15.7 billion of the $26 billion remaining from the 2022 Inflation Reduction Act.